Trials / Completed
CompletedNCT00529646
Single-Dose Safety Study of APD791 in Healthy Volunteers
A Randomized, Double-Blind, Placebo-Controlled, Single-Dose Escalation Study to Assess the Tolerability, Pharmacokinetics, and Pharmacodynamics of APD791 Administered to Healthy Adult Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 90 (estimated)
- Sponsor
- Arena Pharmaceuticals · Industry
- Sex
- All
- Age
- 19 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The APD791-001 study is designed primarily to evaluate the safety and tolerability of APD791 when administered as a single oral dose to healthy adult subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | APD791 |
Timeline
- Start date
- 2007-07-01
- First posted
- 2007-09-14
- Last updated
- 2008-12-30
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00529646. Inclusion in this directory is not an endorsement.